Tonix Pharmaceuticals Holding (TNXP) Assets (2010 - 2026)

Tonix Pharmaceuticals Holding's Assets history runs 17 years deep, the most recent figure standing at $257.9 million for Q1 2026.

• On a quarterly basis, Assets rose 33.72% year-over-year to $257.9 million in Q1 2026; TTM through Mar 2026 was $257.9 million, a 33.72% increase from a year earlier, with the FY2025 full-year figure at $277.2 million, up 70.16% from the prior year.
• Assets retreated to $257.9 million in Q1 2026 per TNXP's latest filing, from $277.2 million in the prior quarter.
• Across five years, Assets topped out at $277.2 million in Q4 2025 and bottomed at $70.3 million in Q2 2024.
• The 5-year median for Assets is $187.4 million (2025), against an average of $190.1 million.
• Across the five-year window, Assets sank 55.99% in 2024 and jumped 166.49% in 2025, its largest moves.
• Year by year, Assets stood at $225.7 million in 2022, then tumbled by 31.56% to $154.5 million in 2023, then advanced by 5.46% to $162.9 million in 2024, then jumped by 70.16% to $277.2 million in 2025, then decreased by 6.95% to $257.9 million in 2026.
• Per Business Quant, the three latest TNXP Assets figures stand at $257.9 million (Q1 2026), $277.2 million (Q4 2025), and $252.4 million (Q3 2025).